'김갑성' 기자의 전체기사
-
TraceLink Supports UNICEF's Traceability and Verification Sys…
TraceLink announced its support for UNICEF's Traceability and Verification System (TRVST), a global initiative improving the safety, authenticity, and traceability of medicines in regions vulnerable to falsified or substandard products. By supporting TRVST, TraceLink reinforces its position as the leading platform for global traceability and patient protection. BOSTON, Dec. 12, 2025 -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced its support for UNICEF's Traceability and Verification System (TRVST
- 김갑성 기자
- 2025-12-12 00:21
-
Suvoda IRT named a Leader in Everest Group's RTSM PEAK Ma…
CONSHOHOCKEN, Pa., Dec. 11, 2025 -- Suvoda, a global clinical trial technology company, today announced that its IRT (Interactive Response Technology) software, also known as RTSM (Randomization and Trial Supply Management), has been recognized as a Leader in Everest Group's PEAK Matrix® assessment for RTSM technology. Everest Group's PEAK Matrix® is a rigorous, data-driven evaluation of technology providers, benchmarking market impact alongside vision and delivery capability. The assessment includes direct customer interviews, providing insight into real-world performa
- 김갑성 기자
- 2025-12-12 00:00
-
Everest Medicines Announces Commercialization Service A…
- Accretive Commercialization Services Agreement covering six mature assets across critical care, cardiovascular, and metabolic disease leveraging Everest's existing commercial organization- Exclusive Greater China license to develop and commercialize Lerodalcibep, a novel, small protein-binding, third-generation PCSK9 inhibitor that adds to the Company's late-stage product pipeline- Together, these agreements drive financial and strategic synergies, improve utilization and productivity of our existing commercial platform, and strengthen commercial capabilities and life-cycle management, whi
- 김갑성 기자
- 2025-12-11 23:57
-
Datasea Announces Breakthrough in Acoustic-Driven Brain…
Developing Healthcare and Intelligent Interaction Through Core Acoustic Innovation BEIJING, Dec. 11, 2025 -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a global technology enterprise specializing in acoustic high-tech innovations and AI multimodal digital solutions, today announced progress in its research and development efforts related to brain–computer interfaces (BCI) technologies. The Company's Real-Time Closed-Loop Vibration-Enhanced BCI System and Acoustic-Coupled EEG Signal Enhancement System have successfully completed engineering-sta
- 김갑성 기자
- 2025-12-11 22:30
-
ProPharma Expands Operations with New Office in Hyderabad
Modern workspace supports continued growth and innovation RALEIGH, N.C., Dec. 11, 2025 -- ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced the official inauguration of its new office in Hyderabad, India, on November 17, 2025. Strategically located in Mindspace, at the heart of Hyderabad's technology corridor (HITEC City/Madhapur), the new office places ProPharma among the world's leading Global Capability Centers (GCCs) in the phar
- 김갑성 기자
- 2025-12-11 21:10
-
HanchorBio Announces Oral Presentation of HCB101 at the ESM…
[ 메디채널 김갑성 기자 ] International debut underscores emerging role for macrophage checkpoint therapy in gastric cancer, triple-negative breast cancer, and other hard-to-treat solid tumors TAIPEI, SHANGHAI, AND SAN FRANCISCO, Dec. 11, 2025 -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced that new clinical data from its flagship macrophage-checkpoint program, HCB101, has been selected for a mini oral presentation at the ESMO Immuno-Oncology Congress 2025 in London, U
- 김갑성 기자
- 2025-12-11 21:00
-
MATELASER W1 REGEN: The Lightest 24g and Highest 5,100 mW/c…
MIAMI, Dec. 11, 2025 -- MATELASER, INC., a pioneer in mobile laser therapy, today announced the official launch of its global crowdfunding campaign for the W1 REGEN, a breakthrough device that brings clinic-grade laser therapy into an ultra-miniature 24g wearable form. Priced at just $99, W1 REGEN officially breaks the cost barrier for true medical-grade photobiomodulation, marking a major step forward in the consumerization of laser therapy. A New Category: Pocket-Sized, Deep-Tissue Laser Therapy Unlike large LED-panel "red light masks" and low-irradiance consumer gad
- 김갑성 기자
- 2025-12-11 20:30
-
The 2nd International Cerebro-cardiovascular Medical Inn…
HONG KONG, Dec. 11, 2025 -- Cerebro-cardiovascular conditions have continued to pose a public health burden. The convergence of population ageing and lifestyle risk factors has made "earlier detection, earlier intervention, and accessible and affordable prevention and management" a common challenge for global healthcare systems. Concurrently, the rapid development of technologies such as Artificial Intelligence (AI), digital health platforms, and medical imaging has brought new possibilities for related risk assessment, early screening, risk stratification, and precision therapy. Ho
- 김갑성 기자
- 2025-12-11 19:19
-
SkyFi Selected for NATO DIANA 2026 Defense Innovation Accelera…
Earth Intelligence Platform Selected to Advance Dual-Use AI Technology for Alliance Security and Resilience AUSTIN, Texas, Dec. 11, 2025 -- SkyFi, the leading Earth observation platform, today announced that it was selected to participate in the North Atlantic Treaty Organization's (NATO) Defence Innovation Accelerator for the North Atlantic (DIANA) 2026 Challenge Programme. SkyFi was selected as one of 150 companies from 3,600 applications across 24 NATO countries through a rigorous evaluation process. SkyFi's intuitive, user-friendly web platform and mobile app enables
- 김갑성 기자
- 2025-12-11 19:00
-
Life-Space Fiber Jelly: The Fiber Fix Modern Guts Have Been…
[ 메디채널 김갑성 기자 ] The smarter, tastier way to meet your daily fiber needs, powered by Litesse for smooth digestion and real gut results. KUALA LUMPUR, Malaysia, Dec. 11, 2025 -- In a world where convenience often outweighs nutrition, Life-Space Fiber Jelly steps in the jelly way to gut health and lightness. The interactive showcase held in Kuala Lumpur, invited attendees to craft their own wholesome oat bowls, pick up mindful nutrition tips, and discover how Life-Space Fiber Jelly, a delicious, jelly-based supplement gives fiber a modern makeover — transforming daily nutrition into a m
- 김갑성 기자
- 2025-12-11 17:57
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 5하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 6대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 7만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2026-01-31_SAT
- Sanyou Bio's Decade: From an Intelligent Super-Trillion Antibody Library to the "Innovation Hub for Original Drug Discovery" 16:15
- CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK 12:05
- Origin Agritech Announces Fiscal Year 2025 Results 06:00
- White Pearl Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering 05:47
- Planet Green Holdings Corp. Provides Response to Unusual Market Action 05:05
- SKF completes previously announced divestment of non-core aerospace operation in Elgin, USA 03:36
- DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion 03:34
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2026년 01월 31일 17시 40분